Search | Clinical Trials Finder

ClinicalTrials.gov public records Last synced Jun 26, 2026, 4:26 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Showing 1–17 of 17 matching trials from the live ClinicalTrials.gov search.

Local D1 index available.

Filters: Condition: Grass Allergy Clear all

Conditions: Type I Hypersensitivity
Interventions: Grass MATA MPL, Placebo; Biological
Lead sponsor: Allergy Therapeutics; Industry
Eligibility: 18 Years to 59 Years
Enrollment: 1,028 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2006 – 2007
U.S. locations: 65
States / cities: Colorado Springs, Colorado • Denver, Colorado • Englewood, Colorado + 58 more

Conditions: Seasonal Allergic Rhinitis, Rhinoconjunctivitis
Interventions: PQ Grass, Placebo; Biological
Lead sponsor: Allergy Therapeutics; Industry
Eligibility: 18 Years to 65 Years
Enrollment: 555 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2023
U.S. locations: 33
States / cities: Centennial, Colorado • Denver, Colorado • Lexington, Kentucky + 27 more

Conditions: Type I Hypersensitivity
Interventions: Grass MATA MPL; Biological
Lead sponsor: Allergy Therapeutics; Industry
Eligibility: 18 Years to 50 Years
Enrollment: 70 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2005
U.S. locations: 11
States / cities: Overland Park, Kansas • North Dartmouth, Massachusetts • St Louis, Missouri + 8 more

Conditions: Seasonal Allergic Rhinitis
Interventions: Placebo (0.5ml), Placebo (1.0ml), Grass MATA MPL (0.5ml) 5100SU, Grass MATA MPL (1.0ml) 10200SU, Grass MATA MPL (1.0ml) 18200SU, Grass MATA (0.5ml) 5100SU; Biological
Lead sponsor: Allergy Therapeutics; Industry
Eligibility: 18 Years to 50 Years
Enrollment: 265 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2017
U.S. locations: 1
States / cities: Neptune City, New Jersey

Conditions: Allergic Conjunctivitis to Tree Pollen or Grass Pollen
Interventions: Fluticasone furoate nasal spray, Placebo nasal spray; Drug
Lead sponsor: Rush University Medical Center; Other
Eligibility: 18 Years to 70 Years
Enrollment: 20 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2009
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Rhinitis, Allergic, Seasonal
Interventions: PQ Grass, Active Placebo, Standard Placebo; Biological · Drug
Lead sponsor: Allergy Therapeutics; Industry
Eligibility: 18 Years to 65 Years
Enrollment: 119 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2021
U.S. locations: 8
States / cities: Lexington, Kentucky • White Marsh, Maryland • Ocean Township, New Jersey + 5 more

Conditions: Allergic Rhinitis
Interventions: Grass MATA MPL 10200, Grass MATA MPL 18200, Placebo; Biological
Lead sponsor: Allergy Therapeutics; Industry
Eligibility: 18 Years to 50 Years
Enrollment: 29 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2016
U.S. locations: 2
States / cities: Neptune City, New Jersey • Newark, New Jersey

Conditions: Allergic Rhinitis, Allergic Rhinitis Due to Grass Pollen, Healthy Volunteers
Interventions: B244 suspension, Vehicle; Biological
Lead sponsor: AOBiome LLC; Industry
Eligibility: 18 Years to 65 Years
Enrollment: 71 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2017 – 2018
U.S. locations: 1
States / cities: Tustin, California

Conditions: Type I Hypersensitivity
Interventions: Grass MATA MPL; Biological
Lead sponsor: Allergy Therapeutics; Industry
Eligibility: 18 Years to 50 Years
Enrollment: 14 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2005
U.S. locations: 1
States / cities: Portland, Oregon

Conditions: Allergy
Interventions: Grazax; Drug
Lead sponsor: ALK-Abelló A/S; Industry
Eligibility: 18 Years to 65 Years
Enrollment: 329 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2006 – 2007
U.S. locations: 1
States / cities: Iowa City, Iowa

Conditions: Rhinitis, Conjunctivitis
Interventions: Grass-SPIRE, Placebo; Drug
Lead sponsor: Circassia Limited; Industry
Eligibility: 12 Years to 75 Years
Healthy volunteers: Healthy volunteers not accepted
Timeline: Started 2016
U.S. locations: 2
States / cities: Canton, Ohio • Cincinnati, Ohio

Conditions: Allergies, Allergic Rhinitis, Asthma
Interventions: sublingual immunotherapy, placebo sublingual immunotherapy; Drug
Lead sponsor: Stanford University; Other
Eligibility: 5 Years and older
Enrollment: 31 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2005 – 2014
U.S. locations: 1
States / cities: Stanford, California

Conditions: Allergy
Interventions: Blood Sampling; Other
Lead sponsor: Adiga Life Sciences, Inc.; Industry
Eligibility: 18 Years to 65 Years
Enrollment: 199 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2017
U.S. locations: 2
States / cities: Upland, California • Fairfax, Virginia

Conditions: Seasonal Allergic Rhinitis
Interventions: Placebo comparator, Grass MATA MPL; Biological
Lead sponsor: Allergy Therapeutics; Industry
Eligibility: 18 Years to 50 Years
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017
U.S. locations: 4
States / cities: Edison, New Jersey • Ocean City, New Jersey • Springfield, New Jersey + 1 more

Conditions: Grass Allergy, Rhinoconjunctivitis
Interventions: Not listed
Lead sponsor: Circassia Limited; Industry
Eligibility: 12 Years to 65 Years
Enrollment: 109 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2015
U.S. locations: 5
States / cities: Washington D.C., District of Columbia • Normal, Illinois • Sylvania, Ohio + 2 more

Conditions: Allergic Rhinitis
Interventions: Dupilumab, Timothy Grass SCIT, Placebo matching dupilumab, Placebo matching SCIT; Drug
Lead sponsor: Regeneron Pharmaceuticals; Industry
Eligibility: 18 Years to 55 Years
Enrollment: 103 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2019
U.S. locations: 12
States / cities: Los Angeles, California • Mountain View, California • Walnut Creek, California + 9 more

Conditions: Immunologic Desensitization
Interventions: allergen extract tablet, Placebo tablet; Drug
Lead sponsor: Virginia Commonwealth University; Other
Eligibility: 18 Years and older
Enrollment: 58 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2016 – 2018
U.S. locations: 1
States / cities: Richmond, Virginia

Search by objective public record fields.

Efficacy and Safety/Tolerability of Grass MATA MPL

Efficacy and Safety of PQ Grass in Subjects With Seasonal Allergic Rhinitis and/or Rhinoconjunctivitis Induced by Grass Pollen

Induction of Immunogenicity With Different Doses of Grass MATA in Subjects Allergic to Grass and Rye Pollen

Dose Selection Study of Efficacy and Safety of Different Doses of Grass MATA MPL and Grass MATA Using mEECs™

Study of the Effect of Fluticasone Furoate Nasal Spray on Spring Allergy Eye Symptoms

An Exploratory Study of PQ Grass 27600 SU

A Study of Tolerability and Safety of Two New Doses of Grass MATA MPL

Study to Assess the Safety, Tolerability, and Preliminary Efficacy of B244 in Healthy Volunteers and Subjects With Seasonal Allergic Rhinitis

Assessment of Residual Allergenicity of Grass/Rye Pollen Allergoid Using Skin Prick Testing

A Trial of Grazax in Subjects With Hayfever

Efficacy and Safety of Grass-SPIRE Registration Study

Sublingual Immunotherapy Studies for Grass and Dust Mite Allergies

Observational Analysis of T Cell Responses to SPIREs for Multiple Allergens in Subjects With Allergy in North America

A Study of Tolerability and Safety of a New Cumulative Dose of Grass MATA MPL

Grass Observational Study

Dupilumab As An Adjunct For Subcutaneous Grass Immunotherapy

Desensitization and Cross-Desensitization During Oral Grass or Ragweed Pollen Immunotherapy